HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
H M Earl Selected Research
H M Earl Research Topics
Disease
12
Breast Neoplasms (Breast Cancer)
01/2021 - 04/2004
4
Neoplasms (Cancer)
08/2017 - 04/2004
2
Neoplasm Metastasis (Metastasis)
03/2013 - 01/2005
2
Nausea
10/2008 - 04/2004
1
Triple Negative Breast Neoplasms
08/2014
1
Residual Neoplasm
03/2013
1
Infections
10/2008
1
Alopecia (Baldness)
10/2008
1
Constipation
10/2008
1
Fatigue
10/2008
1
Stomatitis
10/2008
1
Vomiting
10/2008
1
Ovarian Epithelial Carcinoma
12/2000
1
Ovarian Neoplasms (Ovarian Cancer)
12/2000
Drug/Important Bio-Agent (IBA)
5
Cyclophosphamide (Cytoxan)
FDA Link
Generic
08/2017 - 08/2008
5
Epirubicin (Ellence)
FDA Link
Generic
08/2017 - 08/2008
4
Fluorouracil (Carac)
FDA Link
Generic
08/2017 - 10/2008
2
Docetaxel (Taxotere)
FDA Link
08/2017 - 08/2017
2
Bevacizumab (Avastin)
FDA Link
08/2017 - 08/2017
2
Methotrexate (Mexate)
FDA Link
Generic
10/2012 - 10/2008
2
Paclitaxel (Taxol)
FDA Link
Generic
08/2008 - 12/2000
1
Trastuzumab (Herceptin)
FDA Link
01/2021
1
Biomarkers (Surrogate Marker)
IBA
08/2017
1
B7-H1 Antigen
IBA
07/2015
1
human ERBB2 protein
IBA
08/2014
1
1- (ethoxycarbonyloxymethyl)- 5- fluorouracil
IBA
10/2008
1
Gemcitabine
FDA Link
08/2008
1
Imatinib Mesylate (Gleevec)
FDA Link
01/2005
1
idoxifene
IBA
04/2004
1
Lipids
IBA
04/2004
1
Tamoxifen
FDA Link
Generic
04/2004
1
Cisplatin (Platino)
FDA Link
Generic
12/2000
Therapy/Procedure
4
Neoadjuvant Therapy
08/2017 - 04/2004
3
Drug Therapy (Chemotherapy)
03/2013 - 12/2000
2
Adjuvant Chemotherapy
10/2012 - 08/2008